SCHEMBL3353450

SCHEMBL3353450

CN1CCN(Cc2cn(C)c3ccc([N+](=O)[O-])cc23)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.62
CDK1 P06493 2/20 0.47
CCNB1 P14635 2/20 0.47
CACNB4 O00305 1/20 0.47
CACNA1A O00555 1/20 0.47
CACNA1G O43497 1/20 0.47
CACNG3 O60359 1/20 0.47
CACNA1F O60840 1/20 0.47
CACNA1H O95180 1/20 0.47
CACNB3 P54284 1/20 0.47
CACNA2D1 P54289 1/20 0.47
CACNG7 P62955 1/20 0.47
CACNA1B Q00975 1/20 0.47
CACNA1D Q01668 1/20 0.47
CACNB1 Q02641 1/20 0.47
CACNG1 Q06432 1/20 0.47
CACNB2 Q08289 1/20 0.47
CACNA1S Q13698 1/20 0.47
CACNA1C Q13936 1/20 0.47
CACNA1E Q15878 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3352978 0.91 CACNB4 (0.56) HTR6CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL3356257 0.90 CACNB4 (0.58) HTR6CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL3356418 0.90 HTR6 (0.54) HTR6CDK1CCNB1HTR7LMNA
SCHEMBL3351522 0.89 HTR6 (0.51) HTR6HTR7ALDH1A1LMNACDK2
SCHEMBL3358883 0.88 CTSB (0.59) HTR6CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL9400557 0.81 MAPT (0.51) LMNACDK2
SCHEMBL946393 0.81 HTR6 (0.76) HTR6
SCHEMBL946245 0.81 HTR6 (0.71) HTR6
SCHEMBL3357630 0.80 ALDH1A1 (0.53) HTR6CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL3355596 0.80 ALDH1A1 (0.55) HTR6CACNB4CACNA1ACACNA1GCACNG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed